Parathyroid Adenoma

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 321 Experts worldwide ranked by ideXlab platform

Perolof Hasselgren - One of the best experts on this subject based on the ideXlab platform.

  • synchronous Parathyroid carcinoma Parathyroid Adenoma and papillary thyroid carcinoma in a patient with severe and long standing hyperParathyroidism
    Endocrine Practice, 2009
    Co-Authors: Melanie Goldfarb, Patrick Oneal, Judy L Shih, Pamela Hartzband, James L Connolly, Perolof Hasselgren
    Abstract:

    Objective—To describe a patient presenting with the rare constellation of synchronous Parathyroid carcinoma, Parathyroid Adenoma, and papillary thyroid carcinoma. Methods—Review of clinical presentation, diagnostic workup, surgical management, and pathological findings, and review of pertinent literature. Results—The patient was a 59-year old man who presented with severe clinical manifestations of longstanding primary hyperParathyroidism (HPT), serum calcium of 14.4 mg/dL, and Parathyroid hormone level of 2,023 pg/ml. The patient was found to have a 3.4 cm Parathyroid carcinoma on the left side and a 3.2 cm papillary thyroid carcinoma on the right side. In addition, a 917 mg Parathyroid Adenoma was found on the right side. Conclusion—Synchronous Parathyroid and thyroid carcinomas are extremely rare. Our patient is the first documented case with a Parathyroid Adenoma in addition to synchronous Parathyroid and thyroid carcinomas. The presence of concurrent Parathyroid carcinoma and Adenoma can cause diagnostic confusion and should be considered in patients presenting with severe HPT. Any concomitant thyroid nodules need to be investigated to rule out thyroid carcinoma.

Melanie Goldfarb - One of the best experts on this subject based on the ideXlab platform.

  • synchronous Parathyroid carcinoma Parathyroid Adenoma and papillary thyroid carcinoma in a patient with severe and long standing hyperParathyroidism
    Endocrine Practice, 2009
    Co-Authors: Melanie Goldfarb, Patrick Oneal, Judy L Shih, Pamela Hartzband, James L Connolly, Perolof Hasselgren
    Abstract:

    Objective—To describe a patient presenting with the rare constellation of synchronous Parathyroid carcinoma, Parathyroid Adenoma, and papillary thyroid carcinoma. Methods—Review of clinical presentation, diagnostic workup, surgical management, and pathological findings, and review of pertinent literature. Results—The patient was a 59-year old man who presented with severe clinical manifestations of longstanding primary hyperParathyroidism (HPT), serum calcium of 14.4 mg/dL, and Parathyroid hormone level of 2,023 pg/ml. The patient was found to have a 3.4 cm Parathyroid carcinoma on the left side and a 3.2 cm papillary thyroid carcinoma on the right side. In addition, a 917 mg Parathyroid Adenoma was found on the right side. Conclusion—Synchronous Parathyroid and thyroid carcinomas are extremely rare. Our patient is the first documented case with a Parathyroid Adenoma in addition to synchronous Parathyroid and thyroid carcinomas. The presence of concurrent Parathyroid carcinoma and Adenoma can cause diagnostic confusion and should be considered in patients presenting with severe HPT. Any concomitant thyroid nodules need to be investigated to rule out thyroid carcinoma.

Lisa A Orloff - One of the best experts on this subject based on the ideXlab platform.

  • transoral robotic assisted surgical excision of a retropharyngeal Parathyroid Adenoma a case report
    Head and Neck-journal for The Sciences and Specialties of The Head and Neck, 2015
    Co-Authors: Shethal Bearelly, Brandon L Prendes, Steven J Wang, Christine M Glastonbury, Lisa A Orloff
    Abstract:

    Background Transoral robotic surgery has been used with increasing frequency for oropharyngeal malignancies. We present the first known case of a transoral robotic-assisted Parathyroidectomy. Methods/Results A 77-year-old woman with primary hyperParathyroidism was suspected of having a Parathyroid Adenoma. After several nonlocalizing single photon emission CT/CT sestamibi scans, a neck ultrasound revealed a suspicious low level 6 nodule. Surgical excision of this nodule proved to be a reactive lymph node. She then had a dynamic Parathyroid protocol MRI and CT, which revealed a small retropharyngeal Adenoma candidate. A transoral robotic-assisted surgical approach was utilized to bluntly dissect the retropharyngeal space just above the arytenoids to excise the nodule. After excision, the intraoperative Parathyroid hormone (PTH) normalized and surgical pathology confirmed Parathyroid Adenoma. Conclusion Transoral robotic-assisted surgery is a novel technique that can be utilized for resection of a Parathyroid Adenoma in the retropharyngeal space. © 2015 Wiley Periodicals, Inc. Head Neck 37: E150–E152, 2015

James L Connolly - One of the best experts on this subject based on the ideXlab platform.

  • synchronous Parathyroid carcinoma Parathyroid Adenoma and papillary thyroid carcinoma in a patient with severe and long standing hyperParathyroidism
    Endocrine Practice, 2009
    Co-Authors: Melanie Goldfarb, Patrick Oneal, Judy L Shih, Pamela Hartzband, James L Connolly, Perolof Hasselgren
    Abstract:

    Objective—To describe a patient presenting with the rare constellation of synchronous Parathyroid carcinoma, Parathyroid Adenoma, and papillary thyroid carcinoma. Methods—Review of clinical presentation, diagnostic workup, surgical management, and pathological findings, and review of pertinent literature. Results—The patient was a 59-year old man who presented with severe clinical manifestations of longstanding primary hyperParathyroidism (HPT), serum calcium of 14.4 mg/dL, and Parathyroid hormone level of 2,023 pg/ml. The patient was found to have a 3.4 cm Parathyroid carcinoma on the left side and a 3.2 cm papillary thyroid carcinoma on the right side. In addition, a 917 mg Parathyroid Adenoma was found on the right side. Conclusion—Synchronous Parathyroid and thyroid carcinomas are extremely rare. Our patient is the first documented case with a Parathyroid Adenoma in addition to synchronous Parathyroid and thyroid carcinomas. The presence of concurrent Parathyroid carcinoma and Adenoma can cause diagnostic confusion and should be considered in patients presenting with severe HPT. Any concomitant thyroid nodules need to be investigated to rule out thyroid carcinoma.

Pamela Hartzband - One of the best experts on this subject based on the ideXlab platform.

  • synchronous Parathyroid carcinoma Parathyroid Adenoma and papillary thyroid carcinoma in a patient with severe and long standing hyperParathyroidism
    Endocrine Practice, 2009
    Co-Authors: Melanie Goldfarb, Patrick Oneal, Judy L Shih, Pamela Hartzband, James L Connolly, Perolof Hasselgren
    Abstract:

    Objective—To describe a patient presenting with the rare constellation of synchronous Parathyroid carcinoma, Parathyroid Adenoma, and papillary thyroid carcinoma. Methods—Review of clinical presentation, diagnostic workup, surgical management, and pathological findings, and review of pertinent literature. Results—The patient was a 59-year old man who presented with severe clinical manifestations of longstanding primary hyperParathyroidism (HPT), serum calcium of 14.4 mg/dL, and Parathyroid hormone level of 2,023 pg/ml. The patient was found to have a 3.4 cm Parathyroid carcinoma on the left side and a 3.2 cm papillary thyroid carcinoma on the right side. In addition, a 917 mg Parathyroid Adenoma was found on the right side. Conclusion—Synchronous Parathyroid and thyroid carcinomas are extremely rare. Our patient is the first documented case with a Parathyroid Adenoma in addition to synchronous Parathyroid and thyroid carcinomas. The presence of concurrent Parathyroid carcinoma and Adenoma can cause diagnostic confusion and should be considered in patients presenting with severe HPT. Any concomitant thyroid nodules need to be investigated to rule out thyroid carcinoma.